<DrugInformationSummary id="CDR0000816534"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Afamitresgene autoleucel uses a patient's T cells (a type of immune system cell). In the lab, a special receptor is added to the T cells, allowing them to recognize an antigen (protein) called MAGE-A4, found on some cancer cells. These modified T cells are then grown in large numbers in the lab and infused back into the patient. Once inside the body, afamitresgene autoleucel binds to the MAGE-A4 antigen on cancer cells, helping the immune system to attack and kill the cancer cells. This treatment is a type of cellular immunotherapy called T-cell receptor therapy.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/afamitresgene-autoleucel">Afamitresgene Autoleucel</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000790617">afamitresgene autoleucel</TerminologyLink><GlossaryLink ref="CDR0000816531">afamitresgene autoleucel</GlossaryLink><USBrandNames><USBrandName>Tecelra</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>A-fam-ih-TRES-jeen AW-toh-LOO-sel</TermPronunciation><MediaLink ref="CDR0000817403" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000817404" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab24631f-3364-46e1-8074-7244863bcbab&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Afamitresgene Autoleucel</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab24631f-3364-46e1-8074-7244863bcbab&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Afamitresgene autoleucel
         is approved to treat adults with:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000044626" dictionary="Cancer.gov" audience="Patient">synovial sarcoma</GlossaryTermRef></Strong> that has spread to other parts of the body or cannot be removed by surgery. It is used in patients who have received chemotherapy, who have the blood <GlossaryTermRef href="CDR0000046086" dictionary="Cancer.gov" audience="Patient">antigens</GlossaryTermRef> <GlossaryTermRef href="CDR0000809232" dictionary="Cancer.gov" audience="Patient">HLA-A*02:01P</GlossaryTermRef>, HLA-A*02:02P, HLA-A*02:03P, or HLA-A*02:06P, and whose cancer has the MAGE-A4 antigen.</ListItem>
   </ItemizedList>
  <Para id="_5">Afamitresgene autoleucel is approved under FDAâ€™s <ExternalRef xref="https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm">Accelerated Approval Program</ExternalRef>. As a condition of approval, <GlossaryTermRef href="CDR0000799146" dictionary="Cancer.gov" audience="Patient">confirmatory trial(s)</GlossaryTermRef> must show that it provides a clinical benefit in these patients.</Para><Para id="_4">Afamitresgene autoleucel
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Afamitresgene Autoleucel</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/790617">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-tecelra-synovial-sarcoma-mage-a4">FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy">Immunotherapy to Treat Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C175738">Find Clinical Trials for Afamitresgene Autoleucel</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2024-08-20</DateFirstPublished><DateLastModified>2024-08-29</DateLastModified></DrugInformationSummary>
